Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of Mycobacterium Tuberculosis and resistance markers in sputum specimens
Open Access
- 12 May 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (5) , e0251602
Abstract
Background: The Abbott RealTime MTB is an assay for the detection ofMycobacterium tuberculosis (MTB) complex DNA from respiratory specimens in combination with the Abbott RealTime RIF/INH assay for the detection of genetic resistance markers for isoniazid (INH) and rifampicin (RIF) from MTB positive isolates. Hence, this study aimed to evaluate the performance of the Abbott RealTime MTB and RIF/INH assays.Methods: A cross-sectional study was conducted on 289 study subjects presumptive to have pulmonary tuberculosis at Nigist Eleni Mohammed Memorial Hospital, South Ethiopia from April 2017 to June 2018. Two morning expectorated sputum specimens were collected from each study participant. One sample was tested directly by Xpert MTB/RIF assay at Nigist Eleni Mohammed Memorial Hospital and the other sample was used for smear microscopy, TB culture, Abbott RealTime MTB, and Abbott RealTime INH/RIF assays at International Clinical Laboratories, Addis Ababa, Ethiopia. The diagnostic performance of the Abbott RealTime MTB and INH/RIF assays were calculated against MGIT liquid culture and phenotypic drug susceptibility testing (DST) as the gold standard.Results: For the detection of MTB the Abbott RealTime MTB assay exhibited sensitivity 92.4% (95% CI 83.6–96.9), specificity 95.4% (95% CI 91.1–97.7), PPV 89.0% (95% CI 79.7–94.5) and NPV 96.9% (95% CI 93.0–98.7). For the detection of RIF resistance MTB, Abbott RealTime MTB RIF/INH concurred with phenotypic DST and Xpert MTB/RIF, while for the detection of INH resistance MTB, the sensitivity, specificity, PPV and NPV of the Abbott MTB RIF/INH assay was 84.2% (95% CI 60.4–96.6), 100% (95% CI 89.7–100), 100% and 91.9% (95% CI 80.0–96.9), respectively.Conclusions: The Abbott RTMTB and RIF/INH assays revealed high sensitivity and specificity in MTB diagnosis and provided reliable INH and RIF resistance profiles. This assay has a similar diagnostic performance to the Xpert MTB/RIF assay with the advantages of high-throughput.Keywords
This publication has 18 references indexed in Scilit:
- Diagnosis of active tuberculosis disease: From microscopy to molecular techniquesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2016
- Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, PeruPLOS ONE, 2016
- Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimensTuberculosis, 2015
- Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic ReviewPLOS ONE, 2015
- Drug Resistance Mechanisms in Mycobacterium tuberculosisAntibiotics, 2014
- Characterisation of Mycobacterium tuberculosis isolates lacking IS6110 in Viet NamThe International Journal of Tuberculosis and Lung Disease, 2013
- Cytochrome CYP141: A new target for direct detection of Mycobacterium tuberculosis from clinical specimensActa Microbiologica Et Immunologica Hungarica, 2011
- Treatment Outcomes of Isoniazid-Resistant Tuberculosis Patients, Western Cape Province, South AfricaClinical Infectious Diseases, 2011
- Faculty Opinions recommendation of Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.2009
- Evaluation of PCR Using TRC 4 and IS 6110 Primers in Detection of Tuberculous MeningitisJournal of Clinical Microbiology, 2001